Skip to main content
Search
Home    /    Insights & Resources

Insights & Resources

Start exploring insights from across the industries we serve, featuring the latest industry trends, compliance alerts, tax and accounting news and much more.

Is your transaction a business combination or asset acquisition? Learn how ASC 805 guidance, the screen test and key differences shape reporting.
A medical transportation client needed clarity on true earnings before an acquisition. Weaver guided key decisions, supporting transaction success.
Texas life sciences in 2025 saw concentrated capital, declining innovation output and earlier‑stage clinical shifts shaping the ecosystem.
Texas life sciences saw record capital in Q4 2025, even as innovation, early-stage funding and late-phase clinical trials continued to decline.
Discover the SEC's latest exam priorities for private funds and RIAs to stay compliant and prepared for 2026.
Learn how transfer pricing rules apply to private equity companies that set up employment companies after acquisitions.
Explore Q3 2025 trends in Texas life sciences, from Series B collapse and pipeline bottlenecks to sector divergence and record late-stage capital.
Weaver’s forensic due diligence uncovered hidden risks that helped a private equity firm restructure its deal and reduce exposure.
Explore Weaver’s 2025 Corporate Responsibility Report, featuring our first double materiality assessment and updates on our sustainability progress.
Weaver’s Mike Collier examines recent trends in private equity investments in energy transition projects and the sector’s driving deal activity.
Joining the hosts of Hello, Houston, Mike Collier, partner in Weaver’s Financial Advisory practice, discusses his recent insights on private equity’s role in clean energy transition.
Weaver’s transaction advisory team highlights a recent success guiding a client through a contentious net working capital and earn-out dispute.
1 2 3 4 5